Position in KOD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,167,383
New position
Shares Held
55,631
first reported quarter
Ownership
0.089%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#69
of 200 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Emerald Investment Advisers, LLC holds $33,887,977 across 7 Biotechnology names. KOD ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
46,921 | $14,831,258 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
28,630 | $7,007,765 | |
| 3 | TARS |
Tarsus Pharmaceuticals, Inc.
|
59,747 | $3,760,476 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
131,752 | $3,333,325 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
26,459 | $2,579,223 | |
| 6 | KOD |
Kodiak Sciences Inc.
This page
|
55,631 | $2,167,383 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
5,346 | $208,547 |
All Filings in KOD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,167,383 | 55,631 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||